BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2821529)

  • 1. The propensity to malignancy of dispermic heterozygous moles.
    Wake N; Fujino T; Hoshi S; Shinkai N; Sakai K; Kato H; Hashimoto M; Yasuda T; Yamada H; Ichinoe K
    Placenta; 1987; 8(3):319-26. PubMed ID: 2821529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The propensity to malignancy of dispermic, heterozygous moles].
    Hashimoto M
    Hokkaido Igaku Zasshi; 1987 Jul; 62(4):564-72. PubMed ID: 2960601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant potential of homozygous and heterozygous complete moles.
    Wake N; Seki T; Fujita H; Okubo H; Sakai K; Okuyama K; Hayashi H; Shiina Y; Sato H; Kuroda M
    Cancer Res; 1984 Mar; 44(3):1226-30. PubMed ID: 6318983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The propensity to malignant changes in heterozygous moles].
    Seki T; Fujita H; Okubo H; Shiina Y; Wake N; Ichinoe K; Kuroda M; Satoh H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Dec; 34(12):2221-8. PubMed ID: 7153599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease.
    Zheng XZ; Qin XY; Chen SW; Wang P; Zhan Y; Zhong PP; Buza N; Jin YL; Wu BQ; Hui P
    Mod Pathol; 2020 Oct; 33(10):1979-1988. PubMed ID: 32404958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Complete Hydatidiform Moles: Analysis of a Case Series With Genotyping.
    Bynum J; Murphy KM; DeScipio C; Beierl K; Adams E; Anderson D; Vang R; Ronnett BM
    Int J Gynecol Pathol; 2016 Mar; 35(2):134-41. PubMed ID: 26535984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study for the genesis of trophoblastic tumor, with reference to its androgenetic origin].
    Wake N
    Hokkaido Igaku Zasshi; 1984 Jan; 59(1):21-7. PubMed ID: 6325316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
    Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
    Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of IGF2 and H19 imprinting in choriocarcinoma development.
    Wake N; Arima T; Matsuda T
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S1-8. PubMed ID: 9833609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease.
    Kaneki E; Kobayashi H; Hirakawa T; Matsuda T; Kato H; Wake N
    Cancer Sci; 2010 Jul; 101(7):1717-21. PubMed ID: 20518791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic studies on hydatidiform moles.
    Lawler SD
    Adv Exp Med Biol; 1984; 176():147-61. PubMed ID: 6388257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome and cellular origin of choriocarcinoma.
    Wake N; Tanaka K; Chapman V; Matsui S; Sandberg AA
    Cancer Res; 1981 Aug; 41(8):3137-43. PubMed ID: 7195772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic studies of hydatidiform mole with 46,XY karyotype (author's transl)].
    Ohama K; Okamoto E; Nomura K; Fujiwara A; Fukuda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1664-8. PubMed ID: 6458639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of origin of complete hydatidiform moles.
    Jacobs PA; Wilson CM; Sprenkle JA; Rosenshein NB; Migeon BR
    Nature; 1980 Aug; 286(5774):714-6. PubMed ID: 6447836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two patients with complete hydatidiform mole with 46,XY karyotype.
    Fisher RA; Sheppard DM; Lawler SD
    Br J Obstet Gynaecol; 1984 Jul; 91(7):690-3. PubMed ID: 6743611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lymphocyte antigen expression in hydatidiform mole: androgenesis following fertilization by a haploid sperm.
    Yamashita K; Wake N; Araki T; Ichinoe K; Makoto K
    Am J Obstet Gynecol; 1979 Nov; 135(5):597-600. PubMed ID: 92196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic and clinical features of placental moles: synopsis and update.
    Davis JR
    Cancer Genet Cytogenet; 1986 Jan; 19(1-2):123-7. PubMed ID: 3940172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide single nucleotide polymorphism array analysis unveils the origin of heterozygous androgenetic complete moles.
    Usui H; Nakabayashi K; Maehara K; Hata K; Shozu M
    Sci Rep; 2019 Aug; 9(1):12542. PubMed ID: 31467376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of persistent trophoblastic disease after hydatidiform mole classified by morphology and ploidy.
    Niemann I; Hansen ES; Sunde L
    Gynecol Oncol; 2007 Feb; 104(2):411-5. PubMed ID: 17011616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA Genotyping of Nonmolar Donor Egg Pregnancies With Abnormal Villous Morphology: Allele Zygosity Patterns Prevent Misinterpretation as Complete Hydatidiform Mole.
    Joseph NM; Pineda C; Rabban JT
    Int J Gynecol Pathol; 2018 Mar; 37(2):191-197. PubMed ID: 28463912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.